Prokaryotic expression and activity identification of recombinant human soluble receptor for advanced glycation end products

Abstract

Abstract: Objective To construct a eukaryotic expression vector for His-tagged human soluble receptor for advanced glycation end products (hsRAGE),and study the function and biological activity of the fusion protein. Methods The coding sequence of hsRAGE was amplified from the recombinant pCI-neo/RAGE by PCR method.The fragment was cloned into pET-14b vector and identified by digestion with restriction enzymes and sequence analysis.After transformation of the vector into E.coli BL21(DE3),the fusion protein was expressed successfully in response to IPTG induction in the form of inclusion body.After extraction from the bactrerial cells and washing,the fusion protein was dissolved in 8 mol/L urea and purified using immobilized metal ion affinity chromatography.Renaturing of the fusion protein occurred after gradually removal of the denaturants by dialysis.The protein was subsequently identified by Western blotting,enzyme-linked immunosorbent assay (ELISA) and blockade experiments in the endothelial cells. Results The recombinant hsRAGE/pET-14b was verified by enzyme digestion and sequencing.A fusion protein with a molecular weight of about 45 kD was purified,which could interact with anti-RAGE antibody and AGE and block AGE-induced nuclear factor (NF)-kB activation in the endothelial cells. Conclusions His-hsRAGE fusion protein has been cloned,expressed and purified successfully and identified to possess immunogenicity,binding activity to AGE and blocking effect on AGE-RAGE.

CLC Number:

ZHAO Shan-chao¹, JIANG Yong², LIU Jing-hua², LI Zhi-jie², DENG Peng², ZHANG Gui-lin¹, LIU Zhi-qiang¹, ZHANG Xun¹, HOU Fan-fan¹. Prokaryotic expression and activity identification of recombinant human soluble receptor for advanced glycation end products[J]. Journal of Southern Medical University, 2005, 25(07): 769-773.

References

[1] Hou FF, Jiang JP, Guo JQ, et al. Receptor for advanced glycation end products on human synovial fibroblasts: Role in the pathogenesis of dialysis-related amyloidosis [J]. J Am Soc Nephrol, 2002, 13:1296-130
[2] Katz J, Bhattacharyya I, Farkhondeh-Kish F, et al. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR[J]. J Clin Periodontol, 2005, 32 (1): 40-4.
[3] Bartling B, Hofmann HS, Weigle B, et al. Down-regulation of the receptor for advancedglycation end-products (RAGE)supports non-small cell lung carcinoma [J]. Carcinogenesis,2005, 26 (2): 293-301.
[4] Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of protein[J]. J Biol Chem, 1992, 267(21): 14998-5004.
[5] 赵善超,侯凡凡,姜勇.晚期糖基化终产物受体的结构和功能[J].生理科学进展,2003,34(1):71-3Zhao SC, Hou FF, Jiang Y. The structure and function of RAGE[J]. Prog Physiol Sci, 2003, 34(1): 71-3.
[6] 朱平,唐磊,赵善超,等.抗人晚期糖基化终产物受体胞外段不同表位单克隆抗体的制备[J].第一军医大学学报,2004,24(2):129-32.Zhu P, Tang L, Zhao SC, et al. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advanced glycation end product [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2004, 24(2): 129-32.
[7] 龚小卫,秦清河,王静珍,等.p38MAPK红色荧光蛋白融合载体的构建及表达[J].第一军医大学学报,2002,22(2):171-3Gong XW, Qin QH, Wang JZ, et al. Construction and expression of red fluorescent protein fusion vector incorporating p38 mitogen- activated protein kinase [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(2): 171-3.
[8] 赵善超,刘靖华,李志杰,等.人晚期糖基化终产物受体胞质内段融合蛋白表达载体的构建与表达[J].第一军医大学学报,2003,23(12):1314-6.Zhao SC, Liu JH, Li ZJ, et al. Vector construction for the intracellular domain of human receptor for advanced glycation end- products and expression of the fusion protein[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2003, 23 (12): 1314-6.
[9] Hou FF, Chertow GM, Kay J, et al. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis [J]. Kidney Int,1997, 51(5): 1514-9
[10] Ernst B, Fortunato S, Dietmar S. Influence of reduced intracellular glutathione availability on the secretion of vasoactive substances by human umbilical vein endothelial cells[J]. Hypertens Pregnancy, 2001, 20 (1): 45-56.
[11] 鄂征.组织培养和分子细胞学技术[M].北京出版社,1999.125-6.
[12] Chavakis T, Bierhaus A, Nawroth PP, et al. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response [J]. Microbes Infect. 2004, 6 (13):1219-25.
[13] Basta G, Lazzerini G, Massaro M, et al. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses [J]. Circulation, 2002, 105 (7):816-22.
[14] Bucciarelli L G, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice [J]. Circulation, 2002, 106 (22): 2827-35.
[15] Zeng S, Feirt N, Goldstein M, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice [J]. Hepatology,2004, 39 (2): 422-32.
[16] Wear-Maggitti K, Lee J, Conejero A, et al. Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation [J]. Ann Plast Surg,2004, 52(5): 519-21.